Containing Or Obtained From A Tree Having Matured Height Of At Least Two Meters Patents (Class 424/769)
  • Patent number: 12280134
    Abstract: A tattoo ink particularly useful for light skin. The tattoo ink includes one or more pigment in a carrier solution. The carrier solution includes polyvinyl alcohol, water, ethanol, and a humectant. The humectant may be glycerin or polypropylene glycol or a blend of thereof. The carrier solution may also include witch hazel extract. The polyvinyl alcohol may have a molecular weight range of 30,000 to 85,000 and be at least 98% hydrolyzed.
    Type: Grant
    Filed: November 24, 2021
    Date of Patent: April 22, 2025
    Inventor: Nicholas Weil Mitchell
  • Patent number: 12263201
    Abstract: The invention relates to an extract of Ashwagandha that exhibit enhanced bioactivity and bioavailability comprising of enriched withanolide glycosides and saponins; with negligible amount of alkaloids, withanolide aglycones and oligosaccharides. The extract as disclosed prepared from root, stems, leaves and whole plant of Ashwagandha further shows improved immunomodulatory activity, anti-inflammatory activity, anti stress activity, antidiabetic activity and sleep quality. The disclosure also provides a method of improving bioactivity of withanolide glycosides even at lower doses, by the administration of an enteric coated formulation of extract of Ashwagandha to humans. The enteric coating protects the composition from hydrolysis in the acidic environment of the stomach to release the withanolide glycoside in neutral/alkaline pH in gastrointestinal tract (GIT) thus enhancing the absorption.
    Type: Grant
    Filed: March 10, 2023
    Date of Patent: April 1, 2025
    Assignee: ARJUNA NATURAL PRIVATE LIMITED
    Inventor: Benny Antony
  • Patent number: 12239623
    Abstract: Disclosed herein are compositions comprising two or more sleep-inducing agonists and/or a sleep-inducing antagonist. The compositions are for promoting healthy sleep quality and treating, ameliorating, preventing, or reducing one or more symptoms associated with menopause. Also described herein are methods utilizing the aforementioned compositions.
    Type: Grant
    Filed: May 15, 2024
    Date of Patent: March 4, 2025
    Assignee: Bonafide Health, LLC
    Inventors: James R. Komorowski, Devon Bernsley
  • Patent number: 12235016
    Abstract: A purification device for exercise environment is provided and includes a main body, a purification unit, a gas guider and a gas detection module. The purification unit, the gas guider and the gas detection module are disposed in the main body to guide the gas outside the main body through the purification unit for filtering and purifying the gas, and discharge a purified gas. The gas detection module detects particle concentration of suspended particles contained in the purified gas. The gas guider is controlled to operate and export the gas at an airflow rate within 3 minutes. The particle concentration of the suspended particles contained in the purified gas, which is filtered by the purification unit, is reduced to and less than 0.75 ?g/m3. Consequently, the purified gas is filtered, and an exerciser in an exercise environment can breathe with safety.
    Type: Grant
    Filed: July 8, 2021
    Date of Patent: February 25, 2025
    Assignee: Microjet Technology Co., Ltd.
    Inventors: Hao-Jan Mou, Ching-Sung Lin, Chin-Chuan Wu, Chi-Feng Huang, Yung-Lung Han, Chun-Yi Kuo, Chin-Wen Hsieh
  • Patent number: 12233151
    Abstract: A method for reducing a presence of sebum on skin, reducing an appearance of shiny skin, or reducing an appearance of the size of skin pores, the method comprising topically applying to skin a composition comprising an extract of Bambusa vulgaris wendl shoots, Lonicera japonica leaf extract, and charcoal, wherein topical application of the composition to the skin reduces the presence of sebum on the skin, reduces the appearance of shiny skin, or reduces the appearance of the size of the skin pores.
    Type: Grant
    Filed: November 17, 2022
    Date of Patent: February 25, 2025
    Assignee: MARY KAY INC.
    Inventors: Michael Frushour, Tiffany Carle
  • Patent number: 12213506
    Abstract: Contemplated compositions and methods are based on a combination of polyphenols commonly found in the Mediterranean diet that, when combined, reduce pro-inflammatory signaling and expression of senescence-associated genes and support mitochondrial biogenesis and cellular energy metabolism. Notably, the observed pleiotropic effects did not only span across multiple signaling pathways, but also exhibited synergistic activity with respect to a number of markers associated with reduction of age-related decline in energy, immunity, and increase or persistence of chronic subacute inflammation. Viewed from a different perspective, contemplated compositions represent a symphony of biochemically diverse molecules that form the foundation for numerous benefits typically observed with the Mediterranean diet.
    Type: Grant
    Filed: November 15, 2022
    Date of Patent: February 4, 2025
    Assignee: DailyColors Health Inc.
    Inventor: Hartley Pond
  • Patent number: 12194068
    Abstract: The present disclosure relates to compositions and methods useful for dietary augmentation to provide therapeutic intervention for the treatment and management of acne-prone skin. According to one embodiment of the present disclosure, there is provided an orally administrable composition containing a therapeutically effective amount of: (a) a probiotic blend of bacterial components containing at least: (i) Lactobacillus acidophilus, (ii) Bifidobacterium lactis, an (iii) Bacillus coagulans; (b) guggul; and (c) green tea leaf.
    Type: Grant
    Filed: April 12, 2024
    Date of Patent: January 14, 2025
    Assignee: CODEX LABS CORPORATION
    Inventors: Jessica Maloh, Barbara A. Paldus, Raja Sivamani
  • Patent number: 12171853
    Abstract: Several embodiments disclosed herein relate to formulations having antimicrobial and/or sanitizing effects, and uses of the same. In particular, the formulations and methods of using same provide, in several embodiments, an immediate and a persistent antimicrobial effect against a broad spectrum of microorganisms.
    Type: Grant
    Filed: September 2, 2021
    Date of Patent: December 24, 2024
    Assignee: Innovative BioDefense, Inc.
    Inventors: Jesse Cozean, Colette Cozean, Susan Goldsberry
  • Patent number: 12168076
    Abstract: To prevent or suppress roughness of the skin of a wearer by configuring an absorbent article so as to quickly absorb a body fluid into an absorber, for example, configuring a diaper so as to quickly absorb loose stool into an absorber. An absorbent article includes a liquid-holding absorber and a liquid pervious top sheet on a skin-facing surface side of the absorber. An absorbent Q mainly containing glycerin is provided on an intermediate sheet that transfers at least a body fluid that has passed through the top sheet to the absorber.
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: December 17, 2024
    Assignee: Daio Paper Corporation
    Inventor: Chihiro Kato
  • Patent number: 12161686
    Abstract: Compositions are disclosed herein that comprise a mixture of at least one Albizia extract and a Magnolia extract. In some embodiments, the composition comprises a mixture of at least one Albizia extract enriched for one or more macrocyclic alkaloids and at least one Magnolia extract enrich for one or more lignans.
    Type: Grant
    Filed: December 19, 2022
    Date of Patent: December 10, 2024
    Assignee: Unigen, Inc.
    Inventors: Ping Jiao, Mi sun Oh, Mei Feng Hong, Qi Jia
  • Patent number: 12144881
    Abstract: A cosmetic composition containing ?-mangostin, and use thereof are disclosed. The cosmetic composition includes ?-mangostin and a sunscreen agent. The ?-mangostin is a pure ?-mangostin or an ?-mangostin-containing extract. The sunscreen agent is an inorganic sunscreen agent or an organic sunscreen agent. Herein, the inorganic sunscreen agent is one or more selected from a group of zinc oxide and titanium dioxide. The organic sunscreen agent is a sunscreen agent having a sun protection wavelength range that can be complementary to that of the ?-mangostin or a sunscreen agent that is easily decomposed or easily oxidized under UV exposure. The organic sunscreen agent is one or more selected from a group of butyl methoxydibenzoylmethane, octocrilene, ethylhexyl salicylate, octyl salicylate, homosalate, ethylhexyl methoxycinnamate and terephthalylidene dicamphor sulfonic acid.
    Type: Grant
    Filed: June 24, 2019
    Date of Patent: November 19, 2024
    Assignee: CHINA PHARMACEUTICAL UNIVERSITY
    Inventors: Jinxin Wang, Tingting Zhang
  • Patent number: 12133538
    Abstract: The method for processing fermented or incubated cocoa beans comprises the steps of: adding water to fermented or incubated cocoa beans or nibs to form a suspension; wet grinding said suspension; subjecting said suspension to a heat treatment at a temperature of 70° C. or less; separating the suspension into a water phase (heavy phase), a fat phase (light phase) and a solid phase, said fat phase comprising cocoa butter as a major component and solids and/or water as minor components and said solid phase comprising cocoa powder and water; and separately processing the three phases, which comprises: neutralizing and/or removing acetic acid formed during fermentation or formed or added prior to or during an incubation of the cocoa beans via the water phase, and optionally separating cocoa butter from the fat phase, separating cocoa powder from the solid phase, and separating cocoa aroma and a polyphenolic powder from at least the water phase.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: November 5, 2024
    Assignee: ODC LIZENZ AG
    Inventor: Tilo Hühn
  • Patent number: 12097236
    Abstract: The invention provides to an enriched Withania somnifera (Ashwagandha) extract composition comprising withanolide glycosides, withanolide aglycones and reduced levels of withaferin-A. The invention also provides to process for the preparation of these compositions and further provides to methods of improving testosterone levels, energy levels, sustained energy, vigor, stamina, and muscle mass and muscle strength using these compositions.
    Type: Grant
    Filed: October 19, 2019
    Date of Patent: September 24, 2024
    Assignee: LAILA NUTRACEUTICALS
    Inventors: Ganga Raju Gokaraju, Kiran Bhupathiraju, Rama Raju Gokaraju, Trimurtulu Golakoti, Venkateswarlu Somepalli, Venkata Kanaka Ranga Raju Gokaraju
  • Patent number: 12097276
    Abstract: A composition contains, as an effective component, theasinensin A, an enantiomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof. The composition has an excellent stability and provides wrinkle-reducing or skin elasticity-enhancing benefits, and skin-brightening benefits by containing theasinensin A, an enantiomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, as an effective component.
    Type: Grant
    Filed: November 6, 2019
    Date of Patent: September 24, 2024
    Assignees: AMOREPACIFIC CORPORATION, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
    Inventors: Eun Mi Kim, Kyeonghwan Hwang, Dong Hyun Kim, Byung-Gee Kim, Jinkyung Choi
  • Patent number: 12053536
    Abstract: Disclosed herein are oral care compositions comprising an oral care composition comprising a peroxide whitening complex present in an amount to provide from about 3.0% to about 8% of hydrogen peroxide by weight of the composition; a block copolymer of ethylene oxide and propylene oxide in an amount from about 0.01% to about 8% by weight of the composition; a stearate in an amount from about 0.3% to about 5% by weight of the composition; and a humectant in an amount from about 60% to about 90% by weight of the composition. Methods of making and using the oral care compositions are also provided.
    Type: Grant
    Filed: April 5, 2022
    Date of Patent: August 6, 2024
    Assignee: Colgate-Palmolive Company
    Inventors: Xiang Chen, Suman Chopra
  • Patent number: 12053552
    Abstract: The invention relates to a functional wound dressing being able to detect and indicate the state of the wound, in particular with regard to infections for example caused by toxins produced by bacteria such Staphylococcus aureus and Pseudomonas aeruginosa. The present wound dressing can be used in moist wound healing and contains a substance being able to absorb wound exudate from the wound and to provide moisture to the wound.
    Type: Grant
    Filed: May 13, 2019
    Date of Patent: August 6, 2024
    Assignee: PAUL HARTMANN AG
    Inventors: Markus Kettel, Andrew Tobias Jenkins, Naing Tun Thet
  • Patent number: 12011496
    Abstract: The present invention provides a topical formulation and method of use where the formulation comprises macqui berry or a macqui berry extract containing anthocyanins having a very high oxygen radical absorbance capacity (ORAC). The formulation provides the macqui berry in a stabilized form which includes a glucuronide or glycuronide, a photostabilizing agent, encapsulation, or light- and/or air-blocking packaging.
    Type: Grant
    Filed: May 3, 2021
    Date of Patent: June 18, 2024
    Assignee: Tracie Martyn International, Inc.
    Inventor: Marius Morariu
  • Patent number: 12005075
    Abstract: Combination of dry extract of Rhodiola, dry extract of Trubulus terrestris, dry extract of Undaria pinnatifida, Moringa oleifera, folic acid and vitamin B12 in the form of food supplement for mitigating woman's disorders caused by ageing.
    Type: Grant
    Filed: April 14, 2022
    Date of Patent: June 11, 2024
    Assignee: CRISTALFARMA S.R.L.
    Inventors: Maria Cristina Del Bono, Francesco Bonomo
  • Patent number: 11992545
    Abstract: Aqueous cosmetic compositions comprising at least 20% by weight of an aqueous component and a lipophilic component characterized in that the lipophilic component comprises at least one ester selected from neopentylglycol dipelargonate, glycerol tripelargonate, pentaerythritol tetrapelargonate or mixtures thereof.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: May 28, 2024
    Assignee: NOVAMONT S.P.A.
    Inventors: Luigi Capuzzi, Francesca Digioia, Vanessa Bramati, Federica Carlomagno, Alessandra Cominetti
  • Patent number: 11980664
    Abstract: Pro-toothpaste compositions formulated to receive a volume of allergen solution to provide toothpastes that exhibit efficacy for oral mucosal immunotherapy (OMIT) and acceptable consumer and product stability properties, along with kits of pro-toothpaste, allergen/extracts of allergens, and optionally compounding means and/or specialized toothbrushes are provided. Toothpastes suitable and effective for OMIT and methods for managing allergic symptoms and for reducing risk of allergy in people without symptoms employing the pro-toothpastes, toothpastes and kits of the invention are also disclosed.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: May 14, 2024
    Assignee: ALLOVATE, LLC
    Inventors: Michael Nelson, Erick Berglund
  • Patent number: 11911347
    Abstract: The present invention is in the field of antioxidants and relates to cosmetic or pharmaceutical, preferably dermatological, compositions or homecare product comprising or consisting of a synergistic combination of a specific antioxidant and an effective amount of 1,2-heptanediol and/or 2,3-heptanediol or of a specific alkanediol or a mixture of two or more different specific alkanediols and the use of said compositions as a cosmetic, for personal care, as a pharmaceutical or homecare product, in particular for scavenging reactive oxygen species (ROS), for inhibition matrix metalloproteinases expression and/or for inhibiting interleukin 8 (IL-8) secretion.
    Type: Grant
    Filed: April 14, 2023
    Date of Patent: February 27, 2024
    Assignee: Symrise AG
    Inventors: Nikolas Bugdahn, Sven Siegel, Sabine Lange, Dominik Stuhlmann
  • Patent number: 11896708
    Abstract: This invention illustrates a composition which has a high antioxidant power in cosmetic products. The composition includes a combination of two critical ingredients, originating from two natural superfood products: olive and kale. This current technology utilizes the sprout of kale, instead of the whole plant, as one ingredient. In the perspective of olive extract, it is either in the form of a concentrated liquid syrup of olive tree and leaf, which is enriched with natural polyphenols, especially with high content of hydroxytyrosol, or in the form of pure liquid hydroxytyrosol. An enhanced antioxidant power is observed when incorporating the kale sprouts together with the olive leaf extract.
    Type: Grant
    Filed: September 21, 2021
    Date of Patent: February 13, 2024
    Assignee: Barnet Products LLC
    Inventors: Nickolas Huss, Yiming Lu, Rossana Lanza
  • Patent number: 11891576
    Abstract: Processes for obtaining substances from bark, especially bark high in suberin and lignin, which substances can be used for preparing biofuels are disclosed. The processes use a solvent system for dissolving the substances, which system can be recycled in the process. The solvent system comprises a base selected from tertiary aliphatic amines A composition comprising bark and the solvent system, which can be used in the processes, is also disclosed.
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: February 6, 2024
    Assignee: KAT2BIZ AB
    Inventors: Joseph Samec, Ivan Kumaniaev
  • Patent number: 11849727
    Abstract: Control or repellency of biting arthropods, particularly biting insects, is accomplished by bringing the biting arthropods into contact with combinations of compounds identical or related to those found on human/animal skin or in plants acting synergistically with one another, or in combination with conventional repellents like N,N-diethyl-3-methylbenzamide (DEET®), para-menthane-3,8-diol (PMD), sec-butyl-2-(2-hydroxyethyl) piperidine carboxylate (“Picaridin”), or other nitrogen containing repellents selected from amines, amides and nitrogen containing heterocyclic compounds, or any synergistic combination of DEET®, PMD, Picaridin, or other nitrogen containing repellents selected from amines, amides and nitrogen containing heterocyclic compounds.
    Type: Grant
    Filed: August 11, 2020
    Date of Patent: December 26, 2023
    Assignee: BEDOUKIAN RESEARCH, INC.
    Inventor: Robert H. Bedoukian
  • Patent number: 11839208
    Abstract: The present invention is directed to use of cannabidiol and compositions thereof as an anti-bacterial agent against multi-drug resistant bacteria such as Pseudomonas aeruginosa.
    Type: Grant
    Filed: March 9, 2021
    Date of Patent: December 12, 2023
    Assignee: PHARMOTECH SA
    Inventor: Rodin Aeschbach
  • Patent number: 11839252
    Abstract: A convenient after care cleanser and application method for eyelash extensions allows for easy application, extension of the longevity of the lashes, elimination of protein build-up that eventually accumulates on the lashes, and other benefits.
    Type: Grant
    Filed: May 15, 2020
    Date of Patent: December 12, 2023
    Inventor: Cherie L. Dobbs
  • Patent number: 11820865
    Abstract: The invention relates to vicinal diol ether derivatives of certain polyether polymers, compositions comprising the same, and methods of making the same via reaction with substituted or unsubstituted epoxides, and methods of using the same.
    Type: Grant
    Filed: January 14, 2021
    Date of Patent: November 21, 2023
    Assignee: P2 SCIENCE, INC.
    Inventors: Patrick Foley, Ashoke Bhattacharjee, Tania Salam, Matthew Alan Garcia
  • Patent number: 11801276
    Abstract: Provided are a microorganism having an ability to degrade ethanol and acetaldehyde, and a composition and a kit each including the microorganism.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: October 31, 2023
    Assignee: Medytox Inc.
    Inventors: Young In Kim, Tai Hoon Kim, Hyei Jin Dong, Woo Jin Choi, Hyun Uk Jeong, Seong Gon Hong, Dong Wook Ryu
  • Patent number: 11793754
    Abstract: A nanoemulsion, and a method of preparing the nanoemulsion is disclosed. The nanoemulsion includes sodium hypochlorite (NaOCl), chlorhexidine (CHX), and a self-nanoemulsifying delivery system (SNEDS) which further includes at least one oil, at least one surfactant, and at least one co-surfactant, wherein no parachloroaniline is present in the nanoemulsion after 1 hour at room temperature.
    Type: Grant
    Filed: June 16, 2022
    Date of Patent: October 24, 2023
    Assignee: King Abdulaziz University
    Inventor: Laila Ahmed Salim Bahammam
  • Patent number: 11771730
    Abstract: The present invention relates to a product containing an extract of Rhodiola and an extract of Astragalus as products to be combined for simultaneous administration, separately or staggered over time, in the treatment of a neurodegenerative disease, and in particular for the treatment of Alzheimer's disease and Parkinson's disease.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: October 3, 2023
    Assignee: HUMAN BY NATURE
    Inventor: Gérald Goudet
  • Patent number: 11772030
    Abstract: A miniature gas detection and purification device is disclosed for a user to carry with himself, and includes a main body, a purification module, a gas guider and a gas detection module. The gas detection module detects gas of surrounding environment to obtain a gas detection datum, and controls the gas guider to be operated according to the gas detection datum, so that gas is inhaled into the main body and flows through the purification module for filtration and purification, and the gas purified is finally guided to a region close to the user.
    Type: Grant
    Filed: February 9, 2021
    Date of Patent: October 3, 2023
    Assignee: MICROJET TECHNOLOGY CO., LTD.
    Inventors: Hao-Jan Mou, Yung-Lung Han, Chi-Feng Huang, Chang-Yen Tsai, Wei-Ming Lee, Chun-Yi Kuo, Yang Ku
  • Patent number: 11755996
    Abstract: A method for adjudicating reimbursement for allergens includes obtaining National Drug Codes (NDC's) for a plurality of allergens, storing in a central control database the obtained NDC's in association with an associated AWP and associated information for the allergen, which associated information includes translation information to allow practitioners to determine from a desired diluted level and number of doses of a desired NDC carrying antigen and a known dilution procedure how to translate back to the amount of base concentration of the NDC carrying antigen used to create the desired diluted level and number of doses, and determining if any of the NDC's in the central control database are contained within the third-party database and, if not, transferring the associated NDC's not in the third-party database to the third-party database.
    Type: Grant
    Filed: December 21, 2020
    Date of Patent: September 12, 2023
    Assignee: ROCA MEDICAL LTD.
    Inventors: James Strader, Jovan Hutton Pulitzer
  • Patent number: 11752090
    Abstract: A method for treating skin of a person is disclosed. The method can include topically applying to the skin of the person a composition comprising an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract from Chamaecrista mimosoides, wherein the composition reduces tyrosinase activity in the skin, increases antioxidant activity in the skin, and/or increases skin moisture content.
    Type: Grant
    Filed: March 5, 2021
    Date of Patent: September 12, 2023
    Assignee: MARY KAY INC.
    Inventors: Tiffany Florence, David Gan, Michelle Hines
  • Patent number: 11741606
    Abstract: A digital imaging method of analyzing pixel data of an image of a user's body for determining a user-specific hair removal efficiency value after removing hair is disclosed. The digital imaging method includes: aggregating training images of respective individuals' bodies after removing hair; training, using the pixel data of the training images, a hair removal efficiency model to determine hair removal efficiency values associated with a degree of hair removal efficiencies ranging from a least efficient to a most efficient; receiving an image of a user's body after removing hair; analyzing by the user image using the hair removal efficiency model to determine a user-specific hair removal efficiency value; generating a user-specific electronic recommendation designed to address a feature identifiable within the pixel data of the user's body based on the user-specific hair removal efficiency value; and rendering the recommendation on a display screen of a user computing device.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: August 29, 2023
    Assignee: The Gillette Company LLC
    Inventors: Susan Clare Robinson, Leigh Knight
  • Patent number: 11730787
    Abstract: The present invention relates to a method for treating HIV/AIDS complications including administering a first Chinese herbal medicine composition to a subject in need; wherein the first Chinese herbal medicine composition is an extract of a first mixture including Polygonatum sibiricum, Astragalus membranaceus, Panax ginseng, Liriope spicata, Schisandra chinensis, Ziziphus zizyphus, Cornus officinalis, Fallopia multiflora, and Salvia miltiorrhiza.
    Type: Grant
    Filed: November 8, 2021
    Date of Patent: August 22, 2023
    Inventors: Ying-Chieh Huang, Chen-Yu Lee
  • Patent number: 11607424
    Abstract: Compositions and methods for protecting bees from toxins and for preventing or decreasing colony collapse are provided. The compositions comprise carbon microparticles which, when ingested by bees, increase their survival after exposure to toxins such as pesticides.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: March 21, 2023
    Assignee: Washington State University
    Inventors: Waled Suliman, Brandon Hopkins, Manuel Garcia-Perez
  • Patent number: 11506648
    Abstract: Disclosed is a detection method for quality grade of traditional Chinese medicine (TCM), including: detecting the levels of quality control index components of TCM and efficacy-related in vitro activity by establishing a correlation between principal components of TCM and in vitro activity; determining the state of sample cluster by principal component analysis; constructing a logistic regression model of quality grade versus index components and bioactivity and establishing corresponding grade detection formulas of Chinese medicinal materials by fitting a large number of sample data for Chinese medicinal materials from different places of origin and batches. The method of the present invention realizes the mathematical expression of a standard for quality difference of TCM, and provides a feasible solution for the industrialized evaluation of quality grades of Chinese medicinal materials or herbal slices finally.
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: November 22, 2022
    Assignee: SHAANXI UNIVERSITY OF CHINESE MEDICINE
    Inventors: Zhishu Tang, Yanru Liu, Zhongxing Song, Dahai Jiang, Ningjuan Yang, Aibing Chang, Xiaohong Li
  • Patent number: 11419847
    Abstract: Pharmaceutical micronutrient composition including mixture D in this study helps to mitigate, inhibit, prevent and stop diseases caused by viral infections. The middle east respiratory syndrome-related coronavirus and severe acute respiratory syndrome-related coronavirus as well as their variants and mutants affecting mammals and causing infection are successfully treated using mixture D. Mixture D contains key micronutrients such as an ascorbate, N-acetylcysteine, theaflavins, resveratrol, cruciferous plant extracts, curcumin, quercetin, naringenin, and baicalin and a combination thereof. Additional micronutrients were tested with Mixture D and seemed to have beneficial effects.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: August 23, 2022
    Inventor: Matthias W Rath
  • Patent number: 11351102
    Abstract: The present invention discloses a method for protecting mammalian skin against the harmful effects of UV radiation and environmental pollutants, using one or plant actives selected from group comprising a composition comprising not less than 10% w/w oroxylin A, not less than 10% w/w baicalein and not less than 2% w/w chrysin; 95% w/w oxyresveratrol; 95% w/w tetrahydrocurcumin; 90% w/w pterostilbene and a composition comprising at least 10% w/w ?-glucogallin and at least 10% w/w total mucic acid gallates. The invention also discloses a method for cleansing and rejuvenating mammalian skin, exposed to environmental pollutants and UV radiation using the aforesaid plant actives.
    Type: Grant
    Filed: August 26, 2020
    Date of Patent: June 7, 2022
    Assignee: SAMI-SABINSA GROUP LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Lakshmi Mundkur
  • Patent number: 11337942
    Abstract: Provided are a medical ointment of a novel combination containing paeonol and a pharmaceutical use thereof. The medical ointment of a novel combination includes paeonol and panthenol, and further includes at least one selected from Centella asiatica, coenzyme Q10, neomycin sulfate, and pharmaceutically acceptable salts of these. In the medical ointment of a novel combination, specific ingredients that are effective for local pain relief are mixed with ingredients having other effects in a certain ratio to address the problems of the cut treatment ointment of the related art, so that excellent effects may be obtained in relieving itching and reducing pain while inflammation is effectively treated.
    Type: Grant
    Filed: December 14, 2021
    Date of Patent: May 24, 2022
    Assignee: GENTRIBIO INC.
    Inventors: Chang Keun Yoon, Hong Gyum Kim
  • Patent number: 11331265
    Abstract: The present disclosure is directed to a method for producing an olive branch extract having a high oleuropein content. The method includes crushing at least a portion of dried olive branch and extracting olive branch extract from the crushed olive branch with an extraction solvent. The olive variety is at least one selected from Lucca, Mission, and Nevadillo Blanco. The added branch amount of olive branch to the extraction solvent is 10% by weight or more, the extraction solvent is 30% to 50% 1,3-butylene glycol, and the extraction is performed at a temperature in a range of 70° C. to 80° C.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: May 17, 2022
    Assignee: SHODOSHIMA HEALTHYLAND CO., LTD.
    Inventors: Toshihiro Yagyu, Norihito Kishimoto, Kana Iwata
  • Patent number: 11229589
    Abstract: Described herein is an invention that includes a spreadable conditioning composition comprising a blend of: a branched hydrocarbon and an ester having a kinematic viscosity of less than or equal to about 100 centistokes. The composition may be natural, for example, if each of the branched hydrocarbon and the ester are independently vegetable-derived. In addition, the composition may lack ingredients that are derived from a palm oil. In an embodiment, the composition is a blend of hydrogenated farnesene and an esters selected from glyceryl triheptanoate, dicapryl succinate, heptyl undecylenate, and mixtures thereof. The composition exhibits an average spreading velocity of about 4 to about 8. Also disclosed are formulations for use in products of personal care, home/institutional care, industry, pharmaceutical and medical and veterinary care and related methods.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: January 25, 2022
    Assignee: INOLEX INVESTMENT CORPORATION
    Inventor: Rocco V. Burgo
  • Patent number: 11191744
    Abstract: The invention relates to an active pharmaceutical ingredient consisting exclusively of the combination of (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-)dihydroxyphenyl)-2-propenoyl]oxy}-1,4,5-trihydroxycyclohexanecarboxylic acid and of methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(?-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate for use as a drug or veterinary product, particularly in the prevention and/or treatment of pathological disorders of carbohydrate and/or lipid metabolism.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: December 7, 2021
    Assignees: VALBIOTIS, UNIVERSITE CLERMONT AUVERGNE, UNIVERSITE DE LA ROCHELLE, CNRS
    Inventors: Sebastien Peltier, Vivien Chavanelle, Florian Le Joubioux, Pascal Sirvent, Thierry Maugard
  • Patent number: 11166965
    Abstract: The present invention relates to use of a composition for maintenance of bone and/or cartilage health or prevention, alleviation and/or treatment of bone and/or cartilage disorders.
    Type: Grant
    Filed: May 8, 2020
    Date of Patent: November 9, 2021
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Marie Noelle Horcajada, Fanny Membrez, Elizabeth Offord Cavin
  • Patent number: 11058737
    Abstract: The present invention is directed to a new kind of medicinal value or health care function of Eurycoma longifolia extracts, particularly in the treatment or alleviation symptoms and/or conditions associated to hormonal imbalance in females, including menopause and its related symptoms. In one aspect, the present invention discloses the use of a composition comprising a therapeutically effective amount of Eurycoma longifolia extract in the manufacture of a medicament for the alleviation of symptoms and/or conditions associated to hormonal imbalance in females, including menopause and its related symptoms. The alleviation of the symptoms and/or conditions according to the present invention is characterised by inducing a change in the hormonal contents of estrogen, progesterone, follicle stimulating hormone (FSH) and luteinizing hormone (LH). Also disclosed is the use of a pharmaceutical composition comprising the therapeutically effective amount of Eurycoma longifolia extract.
    Type: Grant
    Filed: October 15, 2019
    Date of Patent: July 13, 2021
    Assignee: BIOTROPICS MALAYSIA BERHAD
    Inventors: Tengku Shahrir Tengku Adnan, Annie George, Sasikala M. Chinnappan
  • Patent number: 10967019
    Abstract: A use of an emblica extract in preparing a pharmaceutical composition for protecting mitochondria in retina is provided. When the pharmaceutical composition, which comprises the emblica extract, is provided to retinal cells, a use of the pharmaceutical composition comprises improvement of the ability of performing the oxidative phosphorylation for the synthesis of the adenosine triphosphate (ATP) by the mitochondria in the retinal cells under or exposed to ultraviolet light, and improvement of the coupling efficiency of the synthesis of the adenosine triphosphate by the mitochondria.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: April 6, 2021
    Assignee: TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
    Inventors: Han-Chung Cheng, Chi-Tang Tu, Shun-Chieh Yang, Man-Ching Shen
  • Patent number: 10967059
    Abstract: Pro-toothpaste compositions formulated to receive a volume of allergen solution to provide toothpastes that exhibit efficacy for oral mucosal immunotherapy (OMIT) and acceptable consumer and product stability properties, along with kits of pro-toothpaste, allergen/extracts of allergens, and optionally compounding means and/or specialized toothbrushes are provided. Toothpastes suitable and effective for OMIT and methods for managing allergic symptoms and for reducing risk of allergy in people without symptoms employing the pro-toothpastes, toothpastes and kits of the invention are also disclosed.
    Type: Grant
    Filed: October 22, 2019
    Date of Patent: April 6, 2021
    Assignee: Allovate, LLC
    Inventors: Michael Nelson, Erick Berglund
  • Patent number: 10961221
    Abstract: The present application relates to novel substituted piperidinyltetrahydroquinolines, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of diabetic microangiopathies, diabetic ulcers on the extremities, in particular for promoting wound healing of diabetic foot ulcers, diabetic heart failure, diabetic coronary microvascular heart disorders, peripheral and cardial vascular disorders, thromboembolic disorders and ischaemias, peripheral circulatory disturbances, Raynaud's phenomenon, CREST syndrome, microcirculatory disturbances, intermittent claudication, and peripheral and autonomous neuropathies.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: March 30, 2021
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Eva Maria Becker-Pelster, Philipp Buchgraber, Anja Buchmüller, Karen Engel, Volker Geiss, Andreas Göller, Herbert Himmel, Raimund Kast, Andreas Knorr, Dieter Lang, Gorden Redlich, Carsten Schmeck, Hanna Tinel, Frank Wunder
  • Patent number: 10953055
    Abstract: An extract of seeds of Emblica officinalis which has triterpenoids and hydroxycinnamic acids is provided. A blend of extracts of seeds of Emblica officinalis which includes an extract of seeds of Emblica officinalis having triterpenoids and hydroxycinnamic acids and an extract of seeds of Emblica officinalis having fatty acids, such as, alpha linolenic acid, linoleic acid and oleic acid is provided. Methods of preparing the extracts of seeds of Emblica officinalis and methods of preparing the blend of extracts of seeds of Emblica officinalis are provided. Methods of treatment administering the extracts of seeds of Emblica officinalis and methods of preparing the blend of extracts of seeds of Emblica officinalis are provided.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: March 23, 2021
    Inventor: Benny Antony
  • Patent number: 10953057
    Abstract: The present invention provides an egg-laying rate-improving agent for egg-laying hens, quails, or broiler breeders, the egg-laying rate-improving agent being characterized by comprising unheated cashew nut shell liquid, heated cashew nut shell liquid, anacardic acid, cardanol, and/or cardol.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: March 23, 2021
    Assignee: IDEMITSU KOSAN CO., LTD.
    Inventors: Eiji Iwamoto, Yuji Shizuno, Yasuhiro Suzuki